Matches in SemOpenAlex for { <https://semopenalex.org/work/W3152149027> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3152149027 abstract "Antibody induction therapy is frequently used as an adjunct to the maintenance immunosuppression in adult kidney transplant recipients. Published data support antibody induction in patients with immunologic risk to reduce the incidence of acute rejection(AR) and graft loss from rejection. However, the choice of antibody remains controversial as the clinical studies were carried out on patients of different immunologic risk and in the context of varying maintenance regimens. Antibody selection should be guided by a comprehensive assessment of immunologic risk, patient comorbidities, financial burden as well as the maintenance immunosuppressives. Lymphocyte-depleting antibody(thymoglobulin, ATGAM or alemtuzumab) is usually recommended for those with high risk of rejection, although it increases the risk of infection and malignancy. For low risk patients, interleukin-2 receptor antibody(basiliximab or daclizumab) reduces the incidence of AR without much adverse effects, making its balance favorable in mostpatients. It should also be used in the high risk patients with other medical comorbidities that preclude usage of lymphocyte-depleting antibody safely. There are many patients with very low risk, who may be induced with intravenous steroids without any antibody, as long as combined potent immunosuppressives are kept as maintenance. In these patients, benefits with antibody induction may be too small to outweigh its adverse effects and financial cost. Rituximab can be used in desensitization protocols for ABO and/or HLA incompatible transplants. There are emerging data suggesting that alemtuzumab induction be more successful than other antibody for promoting less intensive maintenance protocols, such as steroid withdrawal, tacrolimus monotherapy or lower doses of tacrolimus and mycophenolic acid. However, the long-term efficacy and safety of these unconventional strategies remains unknown." @default.
- W3152149027 created "2021-04-13" @default.
- W3152149027 creator A5074031254 @default.
- W3152149027 date "2012-01-01" @default.
- W3152149027 modified "2023-09-27" @default.
- W3152149027 title "Antibody induction therapy in adult kidney transplantation: A controversy continues" @default.
- W3152149027 hasPublicationYear "2012" @default.
- W3152149027 type Work @default.
- W3152149027 sameAs 3152149027 @default.
- W3152149027 citedByCount "0" @default.
- W3152149027 crossrefType "journal-article" @default.
- W3152149027 hasAuthorship W3152149027A5074031254 @default.
- W3152149027 hasConcept C126322002 @default.
- W3152149027 hasConcept C159654299 @default.
- W3152149027 hasConcept C177713679 @default.
- W3152149027 hasConcept C197934379 @default.
- W3152149027 hasConcept C203014093 @default.
- W3152149027 hasConcept C2776760755 @default.
- W3152149027 hasConcept C2777630719 @default.
- W3152149027 hasConcept C2779015954 @default.
- W3152149027 hasConcept C2779134260 @default.
- W3152149027 hasConcept C2779719350 @default.
- W3152149027 hasConcept C2780252810 @default.
- W3152149027 hasConcept C2780303639 @default.
- W3152149027 hasConcept C2780653079 @default.
- W3152149027 hasConcept C2781307858 @default.
- W3152149027 hasConcept C2909675724 @default.
- W3152149027 hasConcept C2911091166 @default.
- W3152149027 hasConcept C71924100 @default.
- W3152149027 hasConceptScore W3152149027C126322002 @default.
- W3152149027 hasConceptScore W3152149027C159654299 @default.
- W3152149027 hasConceptScore W3152149027C177713679 @default.
- W3152149027 hasConceptScore W3152149027C197934379 @default.
- W3152149027 hasConceptScore W3152149027C203014093 @default.
- W3152149027 hasConceptScore W3152149027C2776760755 @default.
- W3152149027 hasConceptScore W3152149027C2777630719 @default.
- W3152149027 hasConceptScore W3152149027C2779015954 @default.
- W3152149027 hasConceptScore W3152149027C2779134260 @default.
- W3152149027 hasConceptScore W3152149027C2779719350 @default.
- W3152149027 hasConceptScore W3152149027C2780252810 @default.
- W3152149027 hasConceptScore W3152149027C2780303639 @default.
- W3152149027 hasConceptScore W3152149027C2780653079 @default.
- W3152149027 hasConceptScore W3152149027C2781307858 @default.
- W3152149027 hasConceptScore W3152149027C2909675724 @default.
- W3152149027 hasConceptScore W3152149027C2911091166 @default.
- W3152149027 hasConceptScore W3152149027C71924100 @default.
- W3152149027 hasLocation W31521490271 @default.
- W3152149027 hasOpenAccess W3152149027 @default.
- W3152149027 hasPrimaryLocation W31521490271 @default.
- W3152149027 hasRelatedWork W137417466 @default.
- W3152149027 hasRelatedWork W2057366582 @default.
- W3152149027 hasRelatedWork W2071053577 @default.
- W3152149027 hasRelatedWork W2073362586 @default.
- W3152149027 hasRelatedWork W2131201627 @default.
- W3152149027 hasRelatedWork W2139992700 @default.
- W3152149027 hasRelatedWork W2318607717 @default.
- W3152149027 hasRelatedWork W2396595528 @default.
- W3152149027 hasRelatedWork W2398267064 @default.
- W3152149027 hasRelatedWork W2466112336 @default.
- W3152149027 hasRelatedWork W25131751 @default.
- W3152149027 hasRelatedWork W2605646834 @default.
- W3152149027 hasRelatedWork W2796631816 @default.
- W3152149027 hasRelatedWork W2801779895 @default.
- W3152149027 hasRelatedWork W3010430700 @default.
- W3152149027 hasRelatedWork W3033846610 @default.
- W3152149027 hasRelatedWork W3141087272 @default.
- W3152149027 hasRelatedWork W42364219 @default.
- W3152149027 hasRelatedWork W87710583 @default.
- W3152149027 hasRelatedWork W379273843 @default.
- W3152149027 isParatext "false" @default.
- W3152149027 isRetracted "false" @default.
- W3152149027 magId "3152149027" @default.
- W3152149027 workType "article" @default.